Jiangsu Hengrui Medicine
600276.SS
#466
Rank
ยฃ34.02 B
Marketcap
ยฃ5.33
Share price
-1.00%
Change (1 day)
-1.56%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Net assets

Net assets on the balance sheet as of September 2024 : ยฃ4.87 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company has ยฃ4.87 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Jiangsu Hengrui Medicine - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$ยฃ4.60 B11.32%
2021-12-31$ยฃ4.13 B19.42%
2020-12-31$ยฃ3.46 B27.21%
2019-12-31$ยฃ2.72 B19.27%
2018-12-31$ยฃ2.28 B25.88%
2017-12-31$ยฃ1.81 B20.67%
2016-12-31$ยฃ1.50 B39.34%
2015-12-31$ยฃ1.07 B27.5%
2014-12-31$ยฃ0.84 B26.85%
2013-12-31$ยฃ0.66 B23.46%
2012-12-31$ยฃ0.54 B20.49%
2011-12-31$ยฃ0.44 B31.67%
2010-12-31$ยฃ0.34 B41.19%
2009-12-31$ยฃ0.24 B18.93%
2008-12-31$ยฃ0.20 B77.48%
2007-12-31$ยฃ0.11 B37.81%
2006-12-31$ยฃ82.88 M4.07%
2005-12-31$ยฃ79.64 M26.64%
2004-12-31$ยฃ62.88 M2.95%
2003-12-31$ยฃ61.08 M0.09%
2002-12-31$ยฃ61.03 M-3.38%
2001-12-31$ยฃ63.16 M